MYH16上调与肺腺癌的攻击性和免疫透有关

Libin Zhang1, Jun Liu2, Han Wang2

  • 1Thoracic Surgery Department, Yan'an Hospital Affiliated to Kunming Medical University, Kunming City, Yunnan Province, China.

概括

髓重链16 (MYH16) 在肺腺癌 (LUAD) 中被上调,与更差的存活率和增加的免疫细胞透相关. 这一发现凸显了MYH16作为LUAD患者潜在的预后指标.